XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
ASSETS    
Cash $ 25,013 $ 18,241
Restricted Cash 441 89
Trade Accounts Receivable, Net of Allowance for Doubtful Accounts of $277 and $292, Respectively 14,533 14,657
Inventories, Net 23,118 26,326
Prepaid Expenses and Other Current Assets 2,900 2,603
Total Current Assets 66,005 61,916
Property, Equipment and Improvements, Net 8,792 7,570
Goodwill 20,201 20,458
Other Intangible Assets, Net 6,670 7,085
Deferred Income Taxes 32 32
Other Non-Current Assets 96 125
Total Assets 101,796 97,186
LIABILITIES AND SHAREHOLDERS' EQUITY    
Accounts Payable 7,260 8,787
Accrued Compensation and Related Benefits 1,641 2,413
Accrued Expenses and Other Current Liabilities 3,342 2,871
Income Taxes Payable 121 168
Total Current Liabilities 12,364 14,239
Deferred Income Taxes 3,904 3,867
Other Non-Current Liabilities 32 31
Total Liabilities 16,300 18,137
Commitments and Contingencies (Note 11)
Shareholders' Equity:    
Preferred Stock – Par Value $.10 Per Share; Authorized 1,000,000 Shares; None Issued
Common Stock – Par Value $.10 Per Share; Authorized 40,000,000 Shares; Issued – 19,976,388 and 19,670,928 Shares, respectively; Outstanding – 15,956,677 and 15,651,217 Shares, respectively 1,998 1,966
Capital in Excess of Par Value 182,246 180,211
Accumulated Deficit (77,709) (82,894)
Accumulated Other Comprehensive Loss (2,473) (1,611)
Treasury Stock - At Cost; 4,019,711 Shares (18,469) (18,469)
Total Ultralife Corporation Equity 85,593 79,203
Non-Controlling Interest (97) (154)
Total Shareholders’ Equity 85,496 79,049
Total Liabilities and Shareholders' Equity $ 101,796 $ 97,186